There is initial evidence that low-dose semaglutide may reduce craving and drinking outcomes in individuals with alcohol-use disorder.

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...

The first time Dr. Fajgenbaum repurposed a drug, it was in an attempt to save his own life. At 25, while in medical school, ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Doctors should prescribe triptans for migraine patients who aren't receiving relief from over-the-counter (OTC) pain ...

DelveInsight's Molecular Glues Market Insights report includes a comprehensive understanding of current treatment practices, ...

The recent approvals and robust pipeline activity are expected to fuel the market of molecular glues in the 7MM during the forecast period 2025-2034 due to factors like improved diagnosis, treatment ...